Scaling iPSC production in different 3D platforms in suspension culture for their use in allogeneic regenerative therapies

被引：1

作者：

Freire-Flores, Danton ^{[1
,2
]}

Kawles, Nyna ^{[1
,2
]}

Caviedes, Pablo ^{[1
,2
,3
]}

Andrews, Barbara A. ^{[1
,2
]}

Asenjo, Juan A. ^{[1
,2
]}

机构：

[1] Univ Chile, Fac Phys & Math Sci, Ctr Biotechnol & Bioengn, Beaucheff 851, Santiago 8370448, Chile

[2] Univ Chile, Dept Chem Engn Biotechnol & Mat, Beaucheff 851, Santiago 8370448, Chile

[3] Univ Chile, Fac Med, Program Mol & Clin Pharmacol, ICBM, Independencia 1027, Santiago 8379482, Chile

来源：

BIOCHEMICAL ENGINEERING JOURNAL | 2025年 / 217卷

关键词：

IPSCs; Stirred-tank bioreactor; Microcarrier; Aggregates; Scaling up; PLURIPOTENT STEM-CELLS; MICROCARRIER CULTURES; EXPANSION;

D O I：

10.1016/j.bej.2025.109672

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Human induced pluripotent stem cells (iPSCs) exhibit significant potential for regenerative medical treatments due to their pluripotency and proliferation capacity. However, the large-scale production required for allogeneic therapies necessitates efficient and scalable culture systems. Conventional 2D culture techniques are inadequate for this, driving interest for innovative bioreactor-based expansion techniques such as microcarrier-based or aggregate cultures. In this study, we compare iPSC expansion and quality in microcarrier and aggregate cultures in spinner flasks, aiming to ascertain which 3D growth configuration yields superior cell mass while maintaining cellular quality. We demonstrated comparable expansion of iPSCs on Cytodex 1 and Cultisphere G microcarriers, as well as in aggregates by day 6 in culture, achieving a final cell density of 2.6 * 106 cells/ml and 5.67 * 106 cells/ml on microcarriers respectively, and 9.76 * 106 cells/ml in aggregates, yielding 4- and 9-fold expansion on microcarriers and 15-fold in aggregates. The efficiency in the recovery of iPSCs as single cells was over 91.5 % for all cultures. iPSCs cultured on microcarriers and as aggregates exhibit OCT3/4, SSEA4, TRA-1-60, and SOX2 pluripotency marker expression, as well as retention of differentiation potential into three germinal layers. This work supports the utilization of microcarriers and aggregates as efficient 3D expansion platforms for suspension cultures of iPSCs.

引用

页数：9

共 31 条

[11] Kwok C.K., Sebastien I., Hariharan K., Meiser I., Wihan J., Altmaier S., Karnatz I., Bauer D., Fischer B., Feile A., Cabrera-Socorro A., Rasmussen M., Holst B., Neubauer J.C., Clausen C., Verfaillie C., Ebneth A., Hansson M., Steeg R., Zimmermann H., Scalable expansion of iPSC and their derivatives across multiple lineages, Reprod. Toxicol., 112, pp. 23-35, (2022)
[12] Laco F., Lam A.T.L., Woo T.L., Tong G., Ho V., Soong P.L., Grishina E., Lin K.H., Reuveny S., Oh S.K.W., Selection of human induced pluripotent stem cells lines optimization of cardiomyocytes differentiation in an integrated suspension microcarrier bioreactor, Stem Cell Res. Ther., 11, 1, (2020)
[13] Mizukami A., Pereira Chilima T.D., Orellana M.D., Neto M.A., Covas D.T., Farid S.S., Swiech K., Technologies for large-scale umbilical cord-derived MSC expansion: experimental performance and cost of goods analysis, Biochem. Eng. J., 135, pp. 36-48, (2018)
[14] Muok L., Sun L., Esmonde C., Worden H., Vied C., Duke L., Ma S., Zeng O., Driscoll T., Jung S., Li Y., Extracellular vesicle biogenesis of three-dimensional human pluripotent stem cells in a novel Vertical-Wheel bioreactor, J. Extracell. Biol., 3, 1, (2024)
[15] Nagamoto Y., Takayama K., Ohashi K., Okamoto R., Sakurai F., Tachibana M., Kawabata K., Mizuguchi H., Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure, J. Hepatol., 64, 5, pp. 1068-1075, (2016)
[16] Nowak-Terpilowska A., Sledzinski P., Zeyland J., Impact of cell harvesting methods on detection of cell surface proteins and apoptotic markers, Braz. J. Med. Biol. Res., 54, 2, pp. 1-7, (2021)
[17] Ornelas-Gonzalez A., Gonzalez-Gonzalez M., Rito-Palomares M., Microcarrier-based stem cell bioprocessing: GMP-grade culture challenges and future trends for regenerative medicine, Critical Reviews in Biotechnology, 41, pp. 1081-1095, (2021)
[18] Pandey P.R., Tomney A., Woon M.T., Uth N., Shafighi F., Ngabo I., Vallabhaneni H., Levinson Y., Abraham E., Ben-Nun I.F., End-to-end platform for human pluripotent stem cell manufacturing, Int. J. Mol. Sci., 21, 1, (2020)
[19] Phillips B.W., Horne R., Lay T.S., Rust W.L., Teck T.T., Crook J.M., Attachment and growth of human embryonic stem cells on microcarriers, J. Biotechnol., 138, 1-2, pp. 24-32, (2008)
[20] Rodrigues A.L., Rodrigues C.A.V., Gomes A.R., Vieira S.F., Badenes S.M., Diogo M.M., Cabral J.M.S., Dissolvable microcarriers allow scalable expansion and harvesting of human induced pluripotent stem cells under xeno-free conditions, Biotechnol. J., 14, 4, (2019)

← 1 2 3 4 →